The most important financial indicators for the company Novotech Clinical Research (Romania) S.r.l. - Unique Identification Number 26215860:
sales in 2023 was
1.082.877
euro, registering a net profit of
17.631
euro and having an average number of
16
employees.
Firma isi desfasoara activitatea in domeniul Cercetare-dezvoltare in alte stiinte naturale si inginerie having the NACE code 7219.
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity. The data show the company's evolution during this period, highlighting any increases or potential decreases recorded.
In the last year of activity, the sales increased by 31.3%, from 827.020 euro in the year 2022, to 1.082.877 euro in 2023.
The Net Profit increased by 5.609 euro, from 12.059 euro in 2022, to 17.631 in the last year.
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.
Debts, Equity, Inventories, Receivables, Accounts, Assets -
Novotech Clinical Research (Romania) S.r.l. - CUI 26215860
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
Fixed Assets
3.448
3.276
4.251
3.719
2.546
1.451
3.299
6.250
11.195
11.790
Current Assets
22.730
53.877
67.056
52.969
71.072
83.024
103.334
110.196
118.840
175.312
Inventories
0
72
88
0
21
72
71
280
120
150
Receivables
18.954
42.022
49.773
42.740
46.707
40.912
47.752
80.440
92.830
109.870
Cash
3.776
11.783
17.195
10.229
24.343
42.041
55.511
29.475
25.890
65.293
Shareholders Funds
8.904
15.851
28.641
39.157
49.807
62.373
71.891
82.153
94.467
111.811
Social Capital
223
225
223
219
215
211
207
202
203
202
Debts
17.275
41.806
42.666
17.530
23.810
22.103
34.743
34.293
35.568
75.291
Income in Advance
0
0
0
0
0
0
0
0
0
0
Exchange rate - RON
4.9465
4.9315
4.9468
4.8371
4.7454
4.6535
4.5681
4.4908
4.445
4.4821
Main CAEN
"7219 - 7219"
CAEN Financial Year
7219
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of
175.312 euro in 2023 which includes Inventories of
150 euro, Receivables of
109.870 euro and cash availability of
65.293 euro.
The company's Equity was valued at
111.811 euro, while total Liabilities amounted to
75.291 euro.
Equity increased by 17.631 euro, from 94.467 euro in 2022, to 111.811 in 2023.
Activate the Financial Reports subscription with unlimited access and check the evolution and current financial situation of any company.
Subscriptions Financial Reports
You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.
Subscription cost is per user. You can pay simultaneously up to 10 users.
RisCo Subscriptions offer the greatest flexibility in choosing the best services according to the needs of each user. These are structured into categories based on the type of service desired, as well as on different service contract periods: monthly, semi-annually, and annually. Check out the subscription offer for the best choices!
Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.
Comments - Novotech Clinical Research (Romania) S.r.l.